Showing results (11-20 of 344) with videos related to

Sort By:
Pageof 35
Expert Review of Endocrinology & Metabolism|February 21, 2019
Liraglutide, the once-daily human GLP-1 analog, in the treatment of Type 2 diabetesMarta Letizia Hribal, Giorgio Sesti
Giornale Italiano Di Cardiologia (2006)|February 3, 2017
[Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk factors and the cardiovascular system]Teresa Vanessa Fiorentino, Giorgio Sesti
Reviews in Cardiovascular Medicine|July 30, 2024
Bempedoic Acid: A New Tool for LDL-Cholesterol Control in Patients with Coronary Artery DiseaseClaudio Bilato, Giorgio Sesti, Maurizio Averna
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 22, 2021
Clinical evaluation of bempedoic acid for the treatment of hyperlipidaemiaMaurizio Averna, Claudio Bilato, Giorgio Sesti, et al.
Diabetes, Obesity & Metabolism|November 29, 2018
PCSK9 inhibitor therapy: A systematic review and meta-analysis of metabolic and cardiovascular outcomes in patients with diabetesMatteo Monami, Giorgio Sesti, Edoardo Mannucci
Cardiovascular Diabetology|October 18, 2015
Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitusPaola Fioretto, Andrea Giaccari, Giorgio Sesti
Giornale Italiano Di Cardiologia (2006)|March 3, 2011
[Glucagon-like peptide-1 analogues: effects on body weight and glycemia]Mariafrancesca Ruffo, Marta Letizia Hribal, Giorgio Sesti
Diabetes/Metabolism Research and Reviews|December 6, 2018
Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicineGaia Chiara Mannino, Francesco Andreozzi, Giorgio Sesti
Current Pharmaceutical Design|May 22, 2013
Role of C reactive protein (CRP) in leptin resistanceMarta Letizia Hribal, Teresa Vanessa Fiorentino, Giorgio Sesti
Pageof 35